Suppr超能文献

中央颅底骨髓炎纵向评估的临床-放射学评价:新型评分系统的建议

Clinico-Radiological Evaluation for Longitudinal Assessment in Central Skull Base Osteomyelitis: Proposal of Novel Scoring System.

作者信息

Upreti Garima, Thomas Regi, Sundaresan Rajan, Rebekah Grace, Rupali Priscilla, Jasper Anitha

机构信息

Skull Base Surgery Unit, Department of Otorhinolaryngology, Christian Medical College, Vellore, Tamil Nadu India.

Present Address: Department of Otorhinolaryngology, All India Institute of Medical Sciences, Rajkot, Gujarat 360006 India.

出版信息

Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):3553-3564. doi: 10.1007/s12070-023-03956-2. Epub 2023 Jul 4.

Abstract

This study aims to evaluate clinical, radiological and laboratory parameters for longitudinal assessment and prognostication in central skull base osteomyelitis (CSBO). Novel radiological score and cranial nerve assessment score (CNAS) have been proposed and analysed along with pain score (VAS), ESR, CRP, WBC count, and HbA1c for utility in disease-monitoring and predicting outcome in CSBO. CSBO cases managed in a tertiary care centre from January 2018 to November 2020, with a minimum follow-up of 6 months were included. The parameters were recorded at presentation, 3-month, 6-month postoperative follow-up, and at completion of therapy, for statistical analysis. Significant positive correlation was found amongst pain score, CNAS, radiological score, ESR, and CRP at different timelines. On longitudinal assessment, there was a statistically significant reduction in above-mentioned parameters, in the cases who recovered. Those with initial radiological score < 30, pain score ≤ 7, and CNAS < 10 showed early clinical improvement, required shorter duration of antimicrobial therapy, and exhibited higher probability of becoming disease-free at an earlier time, compared to those presenting with higher scores. We propose the use of pain score, a novel cranial nerve assessment score, and a novel radiological score for longitudinal assessment in CSBO. The trend in these parameters along with ESR and CRP are useful to monitor the disease process. The initial assessment scores can predict duration of antimicrobial therapy and probability of early recovery. WBC count and HbA1c were neither useful for disease-monitoring nor predicting outcome.

摘要

本研究旨在评估中央颅底骨髓炎(CSBO)纵向评估和预后的临床、影像学及实验室参数。提出并分析了新的影像学评分和颅神经评估评分(CNAS),同时分析了疼痛评分(VAS)、血沉(ESR)、C反应蛋白(CRP)、白细胞计数及糖化血红蛋白(HbA1c),以用于CSBO疾病监测及预测预后。纳入了2018年1月至2020年11月在三级医疗中心接受治疗且随访至少6个月的CSBO病例。在就诊时、术后3个月、6个月随访时及治疗结束时记录参数,用于统计分析。在不同时间点,疼痛评分、CNAS、影像学评分、ESR及CRP之间存在显著正相关。纵向评估显示,康复病例中上述参数有统计学意义的降低。与初始评分较高者相比,初始影像学评分<30、疼痛评分≤7且CNAS<10的患者临床改善更早,抗菌治疗时间更短,且更早实现无病状态的概率更高。我们建议使用疼痛评分、新的颅神经评估评分及新的影像学评分对CSBO进行纵向评估。这些参数连同ESR和CRP的变化趋势有助于监测疾病进程。初始评估评分可预测抗菌治疗时间及早期康复概率。白细胞计数及糖化血红蛋白对疾病监测和预测预后均无帮助。

相似文献

4
Central Skull Base Osteomyelitis in Queensland, Australia, 2010-2020.2010 - 2020年澳大利亚昆士兰州中央颅底骨髓炎
Open Forum Infect Dis. 2024 Oct 10;11(10):ofae614. doi: 10.1093/ofid/ofae614. eCollection 2024 Oct.

引用本文的文献

1
Skull Base Osteomyelitis- Microbiological Profile and Management Implications.颅底骨髓炎——微生物学特征及治疗意义
Indian J Otolaryngol Head Neck Surg. 2025 Jun;77(6):2234-2238. doi: 10.1007/s12070-025-05442-3. Epub 2025 Apr 28.

本文引用的文献

2
Clinical outcomes of otogenic skull base osteomyelitis.耳源性颅底骨髓炎的临床转归。
Eur Arch Otorhinolaryngol. 2021 Aug;278(8):2817-2822. doi: 10.1007/s00405-020-06366-0. Epub 2020 Sep 22.
10
A systematic review of the pain scales in adults: Which to use?成人疼痛量表的系统评价:该用哪个?
Am J Emerg Med. 2018 Apr;36(4):707-714. doi: 10.1016/j.ajem.2018.01.008. Epub 2018 Jan 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验